ATA176789A - Intravenös anwendbare pharmazeutische präparate und verfahren zu ihrer herstellung - Google Patents

Intravenös anwendbare pharmazeutische präparate und verfahren zu ihrer herstellung

Info

Publication number
ATA176789A
ATA176789A AT0176789A AT176789A ATA176789A AT A176789 A ATA176789 A AT A176789A AT 0176789 A AT0176789 A AT 0176789A AT 176789 A AT176789 A AT 176789A AT A176789 A ATA176789 A AT A176789A
Authority
AT
Austria
Prior art keywords
production
pharmaceutical preparations
applicable pharmaceutical
intravenously applicable
intravenously
Prior art date
Application number
AT0176789A
Other languages
English (en)
Other versions
AT402258B (de
Inventor
Erno Dr Orban
Tibor Dr Balogh
Lajos Dr Ila
Gabor Dr Ambrus
Antonia Dr Jekkel
Sandor Dr Elek
Eva Dr Tomori
Istvan Dr Elekes
Sarudy Eva Dr Toth
Imre Moravcsik
Lajos Dr Siklosi
Original Assignee
Biogal Gyogyszergyar
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biogal Gyogyszergyar filed Critical Biogal Gyogyszergyar
Publication of ATA176789A publication Critical patent/ATA176789A/de
Application granted granted Critical
Publication of AT402258B publication Critical patent/AT402258B/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A61K38/13—Cyclosporins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dermatology (AREA)
  • Transplantation (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT0176789A 1988-07-21 1989-07-21 Intravenös anwendbare pharmazeutische präparate und verfahren zu ihrer herstellung AT402258B (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU883796A HU201567B (en) 1988-07-21 1988-07-21 Process for production of intravenous medical compositions containing cyclosphorin

Publications (2)

Publication Number Publication Date
ATA176789A true ATA176789A (de) 1996-08-15
AT402258B AT402258B (de) 1997-03-25

Family

ID=10965544

Family Applications (1)

Application Number Title Priority Date Filing Date
AT0176789A AT402258B (de) 1988-07-21 1989-07-21 Intravenös anwendbare pharmazeutische präparate und verfahren zu ihrer herstellung

Country Status (26)

Country Link
US (1) US5047396A (de)
JP (1) JPH07116051B2 (de)
KR (1) KR0137674B1 (de)
AR (1) AR243382A1 (de)
AT (1) AT402258B (de)
AU (1) AU614862B2 (de)
BE (1) BE1004323A4 (de)
CA (1) CA1332712C (de)
CH (1) CH679120A5 (de)
DD (1) DD283934A5 (de)
DE (1) DE3924207A1 (de)
DK (1) DK175540B1 (de)
FI (1) FI92556C (de)
FR (1) FR2635265B1 (de)
GB (1) GB2221157B (de)
GR (1) GR1002184B (de)
HU (1) HU201567B (de)
IL (1) IL91069A (de)
IT (1) IT1231434B (de)
LU (1) LU87560A1 (de)
NL (1) NL194578C (de)
NO (1) NO175287C (de)
NZ (1) NZ230036A (de)
PT (1) PT91246B (de)
SE (1) SE509174C2 (de)
ZA (1) ZA895588B (de)

Families Citing this family (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6007840A (en) * 1988-09-16 1999-12-28 Novartis Ag Pharmaceutical compositions comprising cyclosporins
GB2222770B (en) * 1988-09-16 1992-07-29 Sandoz Ltd Pharmaceutical compositions containing cyclosporins
GB2251186A (en) * 1990-12-04 1992-07-01 Randall Neal Gatz Polypeptide for use in treatment of autoimmune disease
US6262022B1 (en) 1992-06-25 2001-07-17 Novartis Ag Pharmaceutical compositions containing cyclosporin as the active agent
GB9113872D0 (en) * 1991-06-27 1991-08-14 Sandoz Ag Improvements in or relating to organic compounds
SG45449A1 (en) * 1992-05-13 1998-01-16 Sandoz Ltd Ophthalmic compositions
DK0589843T3 (da) 1992-09-25 2002-04-02 Novartis Ag Cyclosporinholdige farmaceutiske præparater
DE4412201A1 (de) * 1993-04-20 1994-11-10 Rentschler Arzneimittel Neue pharmazeutische Zubereitungen zur oralen Verabreichung enthaltend Cyclosporin
CH686761A5 (de) 1993-05-27 1996-06-28 Sandoz Ag Galenische Formulierungen.
US20020099067A1 (en) * 1993-07-08 2002-07-25 Ulrich Posanski Pharmaceutical compositions for sparingly soluble therapeutic agents
TW406020B (en) * 1993-09-29 2000-09-21 Bristol Myers Squibb Co Stabilized pharmaceutical composition and its method for preparation and stabilizing solvent
DE4340781C3 (de) * 1993-11-30 2000-01-27 Novartis Ag Cyclosporin enthaltende flüssige Zubereitungen und Verfahren zu ihrer Herstellung
KR0146671B1 (ko) * 1994-02-25 1998-08-17 김충환 사이클로스포린-함유 분말 조성물
DE59510233D1 (de) * 1994-11-03 2002-07-11 Novartis Ag Neue zubereitungsformen des cyclosporins zur oralen applikation mit einfacher zusammensetzung und hoher bioverfügbarkeit und verfahren zu deren herstellung
US5904935A (en) * 1995-06-07 1999-05-18 Alza Corporation Peptide/protein suspending formulations
US5827822A (en) * 1996-03-25 1998-10-27 Sangstat Medical Corporation Cyclosporin a formulations as nanoparticles
US5834017A (en) * 1995-08-25 1998-11-10 Sangstat Medical Corporation Oral cyclopsporin formulations
US5962019A (en) * 1995-08-25 1999-10-05 Sangstat Medical Corporation Oral cyclosporin formulations
US5766629A (en) * 1995-08-25 1998-06-16 Sangstat Medical Corporation Oral cyclosporin formulations
MX9702809A (es) * 1995-08-25 1998-02-28 Sangstat Medical Corp Formulaciones orales de ciclosporina.
US20050053594A1 (en) * 1995-11-16 2005-03-10 Dario Alessi RAC-PK as a therapeutic agent or in diagnostics, screening method for agents and process for activating RAC-PK
DE19549852B4 (de) * 1995-11-29 2009-06-04 Novartis Ag Cyclosporin enthaltende Präparate
US5858401A (en) 1996-01-22 1999-01-12 Sidmak Laboratories, Inc. Pharmaceutical composition for cyclosporines
EP0988046B1 (de) 1997-01-30 2004-09-15 Novartis AG Ölfreie pharmazeutische zusammensetzung welche cyclosporin enthält
SI0969856T1 (en) * 1997-03-12 2005-06-30 Abbott Laboratories Hydrophilic binary systems for the administration of cyclosporine
US6346511B1 (en) 1997-09-08 2002-02-12 Panacea Biotec Limited Pharmaceutical composition comprising cyclosporin
US6187747B1 (en) 1997-09-08 2001-02-13 Panacea Biotech Limited Pharmaceutical composition comprising cyclosporin
US6008191A (en) * 1997-09-08 1999-12-28 Panacea Biotec Limited Pharmaceutical compositions containing cyclosporin
AT408186B (de) * 1998-12-15 2001-09-25 Sanochemia Pharmazeutika Ag Wässerige zubereitung von beta-carotin
US7732404B2 (en) 1999-12-30 2010-06-08 Dexcel Ltd Pro-nanodispersion for the delivery of cyclosporin
DE10015814A1 (de) * 2000-03-30 2001-10-11 Max Planck Gesellschaft Arzneimittel zur Stimulierung der Leukopoese, zur Behandlung von Tumor- und Protozoenerkrankungen und Verfahren zu seiner Herstellung
FR2826517B1 (fr) * 2001-06-20 2004-03-12 Somfy Dispositif d'alimentation pour store motorise ou similaire
NZ531946A (en) * 2001-10-19 2005-09-30 Isotechnika Inc Preconcentrate formulations comprising cyclosporin analogue microemulsions that reduce adverse effects while maintaining high bioavailability
US6979672B2 (en) 2002-12-20 2005-12-27 Polichem, S.A. Cyclosporin-based pharmaceutical compositions
US20050059583A1 (en) 2003-09-15 2005-03-17 Allergan, Inc. Methods of providing therapeutic effects using cyclosporin components
US7276476B2 (en) * 2005-07-13 2007-10-02 Allergan, Inc. Cyclosporin compositions
US7202209B2 (en) 2005-07-13 2007-04-10 Allergan, Inc. Cyclosporin compositions
US7297679B2 (en) 2005-07-13 2007-11-20 Allergan, Inc. Cyclosporin compositions
US7288520B2 (en) 2005-07-13 2007-10-30 Allergan, Inc. Cyclosporin compositions
US20070015691A1 (en) * 2005-07-13 2007-01-18 Allergan, Inc. Cyclosporin compositions
US20070015693A1 (en) * 2005-07-13 2007-01-18 Allergan, Inc. Cyclosporin compositions
US7501393B2 (en) * 2005-07-27 2009-03-10 Allergan, Inc. Pharmaceutical compositions comprising cyclosporins
US9839667B2 (en) 2005-10-14 2017-12-12 Allergan, Inc. Prevention and treatment of ocular side effects with a cyclosporin
US7745400B2 (en) * 2005-10-14 2010-06-29 Gregg Feinerman Prevention and treatment of ocular side effects with a cyclosporin
GB2451811A (en) 2007-08-09 2009-02-18 Ems Sa Delivery composition for solubilising water-insoluble pharmaceutical active ingredients
JP4815418B2 (ja) * 2007-10-19 2011-11-16 カヤバ工業株式会社 空圧緩衝器
NZ591261A (en) * 2008-09-12 2012-12-21 Critical Pharmaceuticals Ltd Improvements in the absorption of therapeutic agents across mucosal membranes or the skin
FR2948568B1 (fr) * 2009-07-30 2012-08-24 Sanofi Aventis Formulation pharmaceutique
CA2852056C (en) 2011-03-11 2021-08-10 Beth Israel Deaconess Medical Center, Inc. Anti-cd40 antibodies and uses thereof
CN116063481A (zh) 2015-09-04 2023-05-05 普里玛托普医疗股份有限公司 人源化抗-cd40抗体及其用途

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR3658M (fr) * 1964-02-18 1965-11-02 Michel Marie Andre Guerbet Composition huileuse pour l'injection intravasculaire.
DE2819094A1 (de) * 1977-05-10 1978-11-23 Sandoz Ag Cyclosporin-derivate, ihre verwendung und herstellung
DE2907460A1 (de) * 1978-03-07 1979-09-13 Sandoz Ag Neue resorbierbare galenische kompositionen
CH641356A5 (en) * 1979-02-27 1984-02-29 Sandoz Ag Pharmaceutical compositions containing cyclosporin
AU534955B2 (en) * 1980-01-23 1984-02-23 Sandoz Ag Cyclosporin a to treat lymphoproliferative disorders
DE3339235A1 (de) * 1983-10-28 1985-05-09 Bayer Ag, 5090 Leverkusen Verfahren zur herstellung von polyurethanen
DE3339236A1 (de) * 1983-10-28 1985-05-09 Bayer Ag Arzneimittelzubereitung
AU611961B2 (en) * 1987-10-02 1991-06-27 Vsesojuzny Kardiologichesky Nauchny Tsentr Akademii Meditsinskikh Nauk Sssr Pharmaceutical preparation for curing multiple sclerosis and lateral amyotrophic sclerosis
GB8729153D0 (en) * 1987-12-14 1988-01-27 Efamol Ltd Fatty acid compositions
US4943560A (en) * 1988-04-06 1990-07-24 Regents Of The University Of Minnesota Solvent system for chronic vascular infusion of hydrophobic drugs
DE3832362A1 (de) * 1988-09-23 1990-03-29 Sandoz Ag Neue cyclopeptolide, verfahren zu ihrer herstellung und ihre verwendung

Also Published As

Publication number Publication date
CA1332712C (en) 1994-10-25
SE8902588L (sv) 1990-01-22
FR2635265A1 (fr) 1990-02-16
AR243382A1 (es) 1993-08-31
GB2221157A (en) 1990-01-31
NL194578B (nl) 2002-04-02
KR0137674B1 (ko) 1998-05-15
US5047396A (en) 1991-09-10
ZA895588B (en) 1990-07-25
DE3924207A1 (de) 1990-01-25
SE8902588D0 (sv) 1989-07-21
GR890100467A (el) 1990-06-27
HU201567B (en) 1990-11-28
NL8901902A (nl) 1990-02-16
NO892995L (no) 1990-01-22
AU3884589A (en) 1990-02-01
GB2221157B (en) 1991-12-18
GB8916679D0 (en) 1989-09-06
FR2635265B1 (fr) 1995-03-17
CH679120A5 (de) 1991-12-31
LU87560A1 (fr) 1991-02-18
DE3924207C2 (de) 1992-07-09
FI893520A (fi) 1990-01-22
HUT50851A (en) 1990-03-28
AU614862B2 (en) 1991-09-12
DD283934A5 (de) 1990-10-31
KR900001364A (ko) 1990-02-27
JPH07116051B2 (ja) 1995-12-13
PT91246A (pt) 1990-02-08
DK175540B1 (da) 2004-11-29
BE1004323A4 (fr) 1992-11-03
NZ230036A (en) 1991-02-26
FI92556C (fi) 1994-12-12
FI92556B (fi) 1994-08-31
SE509174C2 (sv) 1998-12-14
DK362189D0 (da) 1989-07-21
AT402258B (de) 1997-03-25
IT8921259A0 (it) 1989-07-21
FI893520A0 (fi) 1989-07-21
IL91069A (en) 1993-07-08
GR1002184B (en) 1996-03-12
NL194578C (nl) 2002-08-05
DK362189A (da) 1990-01-22
PT91246B (pt) 1995-05-04
NO175287C (no) 1994-09-28
JPH03115227A (ja) 1991-05-16
IT1231434B (it) 1991-12-04
NO175287B (no) 1994-06-20
NO892995D0 (no) 1989-07-21

Similar Documents

Publication Publication Date Title
ATA176789A (de) Intravenös anwendbare pharmazeutische präparate und verfahren zu ihrer herstellung
DE58904479D1 (de) Pharmazeutische zubereitung sowie verfahren zu ihrer herstellung.
ATA125988A (de) Pharmazeutische cefuroximaxetil-zusammensetzung und verfahren zu ihrer herstellung
ATA315488A (de) Neue adenosinderivate, verfahren zu deren herstellung und sie enthaltende pharmazeutische praeparate
ATA112089A (de) Harzadsorbat ranitidinpräparate und verfahren zu ihrer herstellung
DE59008160D1 (de) Feste pharmazeutische Präparate und Verfahren zu ihrer Herstellung.
DE68907876D1 (de) Substanz dc 113 und verfahren zu ihrer herstellung.
PT79007A (de) Regulatorische peptide enthaltende pharmazeutische praeparate mit protrahierter freisetzung und verfahren zu deren herstellung
ATA293589A (de) Neue chinolinsulfonaminoderivate und verfahren zu deren herstellung sowie pharmazeutische zusammensetzung
ATA119188A (de) Pharmazeutische granulate und verfahren zu ihrer herstellung
DE68917798D1 (de) Anschlussstruktur und Verfahren zu deren Herstellung.
DE3483899D1 (de) Cephalosporinderivate, verfahren zu ihrer herstellung und pharmazeutische praeparate.
DE68908374D1 (de) Propenonoximether, verfahren zu dessen herstellung sowie diese enthaltende arzneinmittel.
DE3881950D1 (de) Azabicyclische verbindungen, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zubereitungen.
ATA247489A (de) Festes pharmazeutisches piroxicam-präparat und verfahren zu seiner herstellung
DE69326569D1 (de) Sterinderivate, Verfahren zu ihrer Herstellung und dermatologische Präparate
ATE143010T1 (de) Pyridazin-derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen
DE3484925D1 (de) Pyrazolochinoline, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zubereitungen.
DE68901039D1 (de) Indolylpiperidin-derivate, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische verbindungen.
DE68927880D1 (de) Verzweigte polycarbonate und verfahren zu ihrer herstellung
DE3766299D1 (de) 4-chinolon-3-carbonsaeurederivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate.
DE68910523D1 (de) Trizyklische 3-oxo-propannitril-derivate und verfahren zu deren herstellung.
DE68908464D1 (de) Nadelfoermige titandioxydteilchen und verfahren zu ihrer herstellung.
DE3674521D1 (de) 6-phenoxymethyl-4-hydroxytetrahydropyran-2-one, verfahren zu ihrer herstellung, ihre verwendung als arzneimittel, pharmazeutische praeparate und zwischenprodukte.
ATA146488A (de) 2-methoxymethylpenemverbindungen, verfahren zu deren herstellung und sie enthaltende pharmazeutische zusammensetzungen

Legal Events

Date Code Title Description
REN Ceased due to non-payment of the annual fee
EFA Change in the company name
ELA Expired due to lapse of time